Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
Therapeutic Innovation & Regulatory Science|January 30, 2022
Protocol Design Variables Highly Correlated with, and Predictive of, Clinical Trial PerformanceZachary Smith, Ralf Bilke, Sybrand Pretorius, et al.Therapeutic Innovation & Regulatory Science|April 5, 2022
Benchmarking Protocol Deviations and Their Variation by Major Disease CategoriesKenneth Getz, Zachary Smith, Ananya Jain, et al.Therapeutic Innovation & Regulatory Science|December 1, 2020
Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsKenneth Getz, Zachary Smith, Laura Shafner, et al.Therapeutic Innovation & Regulatory Science|June 10, 2022
Global Investigative Site Personnel Diversity and Its Relationship with Study Participant DiversityKenneth Getz, Maria Florez, Emily Botto, et al.Therapeutic Innovation & Regulatory Science|January 9, 2024
Quantifying Site Burden to Optimize Protocol PerformanceMaria Florez, Zachary Smith, Zachary Olah, et al.Therapeutic Innovation & Regulatory Science|June 18, 2020
Benchmarking Patient Recruitment and Retention PracticesMary Jo Lamberti, Zachary Smith, Rhonda Henry, et al.Pharmaceutical Medicine|January 15, 2020
Reflections on the Evolution of Patient Engagement in Drug DevelopmentKenneth GetzInternational Journal of Environmental Research and Public Health|May 15, 2014
Improving protocol design feasibility to drive drug development economics and performanceKenneth GetzDrug Safety|June 26, 2015
Evaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting PracticesStella Stergiopoulos, Kenneth GetzAmerican Journal of Therapeutics|January 29, 2008
Racial disparities among clinical research investigatorsKenneth Getz, Laura FadenPageof 17